Search research articles
Contact Us
Filters
Showing results (41-50 of 201) with videos related to
Page
of 21
Sort By:
Current Diabetes Reports
|
April 15, 2018
Renal Effects of Incretin-Based Diabetes Therapies: Pre-clinical Predictions and Clinical Trial Outcomes
Scott C Thomson, Volker Vallon
Experimental Physiology
|
August 3, 2014
Intestinal regulation of urinary sodium excretion and the pathophysiology of diabetic kidney disease: a focus on glucagon-like peptide 1 and dipeptidyl peptidase 4
Volker Vallon, Neil G Docherty
Clinical Pharmacology and Therapeutics
|
June 11, 2022
Protecting the Kidney: The Unexpected Logic of Inhibiting a Glucose Transporter
Volker Vallon, Young Chul Kim
Nature Reviews. Endocrinology
|
June 2, 2011
Anomalous role for dietary salt in diabetes mellitus?
Volker Vallon, Scott C Thomson
The American Journal of Cardiology
|
November 20, 2019
Renal Effects of Sodium-Glucose Co-Transporter Inhibitors
Scott C Thomson, Volker Vallon
Nature Reviews. Nephrology
|
March 11, 2020
The tubular hypothesis of nephron filtration and diabetic kidney disease
Volker Vallon, Scott C Thomson
Diabetologia
|
November 24, 2016
Targeting renal glucose reabsorption to treat hyperglycaemia: the pleiotropic effects of SGLT2 inhibition
Volker Vallon, Scott C Thomson
Kidney & Blood Pressure Research
|
November 19, 2002
Protein kinase C beta isoenzymes in diabetic kidneys and their relation to nephroprotective actions of the ACE inhibitor lisinopril
Imke L Pfaff, Volker Vallon
American Journal of Physiology. Renal Physiology
|
March 1, 2021
Effects of SGLT2 inhibitor and dietary NaCl on glomerular hemodynamics assessed by micropuncture in diabetic rats
Scott Culver Thomson, Volker Vallon
American Journal of Physiology. Renal Physiology
|
January 25, 2018
SGLT2 inhibition in a kidney with reduced nephron number: modeling and analysis of solute transport and metabolism
Anita T Layton, Volker Vallon
Page
of 21
Search research articles
Search
Showing results (41-50 of 201) with videos related to
Sort By:
Page
of 21
Current Diabetes Reports
|
April 15, 2018
Renal Effects of Incretin-Based Diabetes Therapies: Pre-clinical Predictions and Clinical Trial Outcomes
Scott C Thomson, Volker Vallon
Experimental Physiology
|
August 3, 2014
Intestinal regulation of urinary sodium excretion and the pathophysiology of diabetic kidney disease: a focus on glucagon-like peptide 1 and dipeptidyl peptidase 4
Volker Vallon, Neil G Docherty
Clinical Pharmacology and Therapeutics
|
June 11, 2022
Protecting the Kidney: The Unexpected Logic of Inhibiting a Glucose Transporter
Volker Vallon, Young Chul Kim
Nature Reviews. Endocrinology
|
June 2, 2011
Anomalous role for dietary salt in diabetes mellitus?
Volker Vallon, Scott C Thomson
The American Journal of Cardiology
|
November 20, 2019
Renal Effects of Sodium-Glucose Co-Transporter Inhibitors
Scott C Thomson, Volker Vallon
Nature Reviews. Nephrology
|
March 11, 2020
The tubular hypothesis of nephron filtration and diabetic kidney disease
Volker Vallon, Scott C Thomson
Diabetologia
|
November 24, 2016
Targeting renal glucose reabsorption to treat hyperglycaemia: the pleiotropic effects of SGLT2 inhibition
Volker Vallon, Scott C Thomson
Kidney & Blood Pressure Research
|
November 19, 2002
Protein kinase C beta isoenzymes in diabetic kidneys and their relation to nephroprotective actions of the ACE inhibitor lisinopril
Imke L Pfaff, Volker Vallon
American Journal of Physiology. Renal Physiology
|
March 1, 2021
Effects of SGLT2 inhibitor and dietary NaCl on glomerular hemodynamics assessed by micropuncture in diabetic rats
Scott Culver Thomson, Volker Vallon
American Journal of Physiology. Renal Physiology
|
January 25, 2018
SGLT2 inhibition in a kidney with reduced nephron number: modeling and analysis of solute transport and metabolism
Anita T Layton, Volker Vallon
Page
of 21